fda warning bpc-157 not approved for human use BPC 157 Banned: Key Facts on the EVEXIAS Life Sciences filing lawsuit
Description
However, controversy remains regarding the true utility of these studies
PMID: 41901308
The main risks come from unregulated sourcing
They can help you learn what to expect and when to seek further care
An earlier Phase II trial11 and two essentially identical Phase III trials (a study of at least moderate size that compares a new treatment with the current standard of care in patients), Gout 1 and Gout 2 have been presented.13 Data on shrinkage of tophi with this agent was also presented in 6/09.13 Cardiac events have occurred during the studies of Krystexxa, and the FDA reviewed them closely and concluded that they did not appear due to the medication
